A study to evaluate the effect of Krishna Tila Churna with Navneet in Raktja Arsha (Haemorrhoids).
Phase 2
Completed
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2021/11/038138
- Lead Sponsor
- DR DEEP PRAKASH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1) Patients diagnosed as Raktja Arsha.
2) 1st and 2nd degree haemorrhoids.
3) Patients of age group between 18 upto 60 years irrespective of gender will be included.
Exclusion Criteria
1) Patients not willing for trial
2) Pregnant women
3) Patients that need surgical intervention
4) Diseases like Ulcerative colitis, Crohns disease, TB of colon or rectum, Rectal prolapse, CA of rectum or an malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of Krishna Tila Churna with Navneet in management of Rakatja Arsha.Timepoint: The drug will be given twice a day for 7 days. <br/ ><br>Follow-ups will be on 3rd and 7th day. <br/ ><br>Total duration of the study will be 7 days.
- Secondary Outcome Measures
Name Time Method 1) To observe the adverse effects of the drug.Timepoint: The drug will be given twice a day for 7 days. <br/ ><br>Follow-ups will be on 3rd and 7th day. <br/ ><br>Total duration of study will be 7 days.